Benperidol
- Level
- Commodity
- Parent
- 51332500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51332504This classification denotes a dopamine antagonist with the molecular formula C22H24FN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 97O6X78C53, chemically known as 2h-benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl)-1,3-dihydro- but generally known as benperidol, which bears US NIH Compound Identifier 16363. Benperidol most often comes in base and hydrochloride forms. European Medicines Agency schedules Benperidol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05727MIG. The term BENPERIDOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules benperidol in its Anatomical Therapeutic Chemical (ATC) Classification. BENPERIDOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benperidol under HS 29333999 and SITC 51574. As of Q4 2014, BENPERIDOL remains the US FDA Preferred Term for this commodity. Benperidol bears US NLM identifiers UMLS ID C0005013 and NCI Concept Code C81086. SMILES: FC1CCC(C(=O)CCCN2CCC(N3C4C([NH]C3=O)CCCC4)CC2)CC1.
Same parent
Under 51332500 · 27Activities that produce or sell this
KBLI · 8Inherited from family 51330000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.